Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.

Stroupe KT, Smith BM, Lee TA, Tarlov E, Durazo-Arvizu R, Huo Z, Barnett T, Cao L, Burk M, Cunningham F, Hynes DM, Weiss KB.

Med Care. 2007 Nov;45(11):1090-7.

PMID:
18049350
2.

Effect of a medication copayment increase in veterans with schizophrenia.

Zeber JE, Grazier KL, Valenstein M, Blow FC, Lantz PM.

Am J Manag Care. 2007 Jun;13(6 Pt 2):335-46.

3.

Copayments for medications. Interim final rule.

Department of Veterans Affairs.

Fed Regist. 2009 Dec 31;74(250):69283-5.

4.

Copayments for medications after June 30, 2010. Final rule.

Department of Veterans Affairs.

Fed Regist. 2011 Feb 22;76(35):9646-8.

5.

Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.

Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF.

Am J Manag Care. 2010 Jan 1;16(1):e20-34.

6.

Copayments for medications in 2013. Interim final rule.

Department of Veterans Affairs.

Fed Regist. 2012 Dec 31;77(250):76865-7.

7.

Copayments for medications after June 30, 2010. Interim final rule.

Department of Veterans Affairs.

Fed Regist. 2010 Jun 9;75(110):32670-3.

8.

Effect of copayments on drug use in the presence of annual payment limits.

Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J.

Am J Manag Care. 2007 Jun;13(6 Pt 2):328-34.

9.

Does the association between prescription copayment increases and medication adherence differ by race?

Wong ES, Maciejewski ML, Liu CF.

J Health Care Poor Underserved. 2013 Aug;24(3):1317-30. doi: 10.1353/hpu.2013.0152.

PMID:
23974401
10.

Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.

Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG.

Circulation. 2009 Jan 27;119(3):390-7. doi: 10.1161/CIRCULATIONAHA.108.783944. Epub 2009 Jan 12.

11.

Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.

Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan SD.

Am J Manag Care. 2011 Oct;17(10):703-10.

PMID:
22106463
12.

Copayments for medication in 2014. Final rule.

Department of Veterans Affairs.

Fed Regist. 2014 May 27;79(101):30043-4.

13.

Copayments for medications. Final rule.

Department of Veterans Affairs.

Fed Regist. 2010 Jun 9;75(110):32668-70.

14.

Copayments for medications in 2013. Final rule.

Department of Veterans Affairs.

Fed Regist. 2013 May 23;78(100):30767-8.

15.

The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration.

Johnson ML, Petersen LA, Sundaravaradan R, Byrne MM, Hasche JC, Osemene NI, Wei II, Morgan RO.

Ann Pharmacother. 2009 Oct;43(10):1565-75. doi: 10.1345/aph.1L606. Epub 2009 Aug 25.

PMID:
19706740
16.

Copayments for medications in 2012. Final rule.

Department of Veterans Affairs.

Fed Regist. 2012 May 14;77(93):28258-9.

17.

Copayments for medications in 2014. Interim final rule.

Department of Veterans Affairs.

Fed Regist. 2013 Dec 30;78(250):79315-7.

18.

Out-of-pocket pharmacy expenditures for veterans under medicare part D.

Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M.

Med Care. 2007 Oct;45(10 Supl 2):S77-80.

PMID:
17909387
19.

Incentive formularies and changes in prescription drug spending.

Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.

Am J Manag Care. 2007 Jun;13(6 Pt 2):360-9.

20.

Exempting in-home video telehealth from copayments. Direct final rule; confirmation of effective date.

Department of Veterans Affairs.

Fed Regist. 2012 Sep 25;77(186):58952-3.

Supplemental Content

Support Center